Three Sydney Space-Physics Papers Outlasted a 2023 Fabrication Finding Against Their First Author
A 2023 Sydney inquiry found Joachim Schmidt fabricated a figure in an unpublished manuscript. Journals now say figures in three of his published papers were likely fabricated too, and those retractions began with an anonymous complaint to the publisher in 2024.
InvestigationsFrom 'Vaccine Hesitancy' to 'Trust': Five Years of NIH Insiders Grading Vaccine-Injury Research by Public Reaction
In 2021 Francis Collins warned that a paper on nerve symptoms after COVID vaccination would feed 'vaccine hesitancy.' This month the NIH hospital board's chair warned the new clinic's findings would be dismissed either way. Of decided federal COVID countermeasure claims, 98.4 percent were denied.
InvestigationsThe CDC's Flu-Shot Effectiveness Figures Come Out of a Regression Model, Not a Trial
The CDC's 41 percent flu-shot figure for seniors comes from a regression run on sick clinic patients, and the study's own tables show timing, exclusion and healthy-vaccinee biases built into it.
InvestigationsThe Byline Broker Signed Its Sales Pitch With a London Oncologist's Name
Springer Journals Online sold co-author slots on papers it said were nearly through review at Elsevier, Wiley and Springer Nature, and signed the pitch with a cancer researcher's name. Its website is gone. The manuscripts have not been publicly identified.
InvestigationsThe 33 Infections the CDC's 90 Percent Vaccine Number Left Out
In March 2021 the CDC announced that mRNA vaccines cut infection risk by 90 percent. Its own report set aside 33 infections that struck in the days after the shot, and a peer-reviewed critique shows how that counting rule can make a useless vaccine look 48 percent effective.
InvestigationsNew York Keeps 51 Cents of Every Dollar Its Gamblers Lose, and the Addiction Tripwire It Just Proposed Doesn't Trip Until a $10,000 Single-Day Deposit
New York taxes sportsbooks on the money bettors lose at 51 percent and has booked $3.89 billion since 2022. The at-risk rules its Gaming Commission proposed October 9 adopt New Jersey's model, whose deposit trigger DraftKings already meets: more than $10,000 in a single day.
InvestigationsPhysics of Fluids Sent a Postdoc's Name to the Authors Whose Algebra He Flagged
AIP Publishing tells its editors to protect the anonymity of anyone raising a concern. Physics of Fluids sent a postdoc's name, institution and rank to the authors he challenged, and 8 referees later found nothing to defend in their paper.
InvestigationsThe FDA Will Now Accept Real-World Evidence for Devices Without the Patient Records Behind It
The curation that turns raw medical charts into "regulatory-grade" evidence happens inside private vendors like Roche-owned Flatiron Health. The public record does not show who, if anyone, independently audits it.
InvestigationsThe WHO Halted a Global Drug Trial on Data a Tiny Company Would Not Let Auditors See
Ninety-six thousand patients across six continents, supplied by a Chicago firm that would not open its database to independent auditors, and the WHO changed course in days.
InvestigationsThe Ebola Vaccine 2,000 Congolese Frontline Workers Received Isn't Known to Work on the Strain Killing Them
Bundibugyo Ebola has no licensed vaccine, so the response is dosing frontline workers with Ervebo, approved only against a different strain, while the State Department fast-tracks $50 million to CEPI and a four-candidate portfolio that includes Moderna, in an outbreak the surveillance system missed
InvestigationsThe Zombie Papers: Retracted Stem-Cell Studies Still Feeding the Unproven-Cure Marketplace
A stem-cell paper retracted in November 2021 kept collecting citations for years, 72 by mid-2026, 27 of them after the notice went up, 15 since 2023 that never mention it. Two researchers counted, and named who is supposed to be cleaning up.
InvestigationsA Journal Built to Critique Capitalism Sold for €360,000. Its Fifteen Editors Read the New Fees and Quit.
A €360,000 sale, a €1,350 charge to publish, and a 25 percent fee to withdraw your own paper: the board of a journal built to critique capitalism read the new terms and resigned en masse.
InvestigationsThe Government Calls the AMA's Codes a 'Monopoly.' The Government Made Them Mandatory.
Royalties bring the American Medical Association more than half its revenue, $301.4 million in 2024, and the code set behind them is one federal rules make mandatory. This summer, CMS asked the public what that arrangement costs.
InvestigationsThe FDA Erased Its Ivermectin Posts and Admitted Nothing. The Doctors' Records Kept the Punishment.
The agency deleted its 'you are not a horse' posts to end a lawsuit, but by then Bowden had lost hospital privileges, Marik had resigned his university chair, and Apter had been referred to two state boards.
InvestigationsA Chinese Registry Marked the Trial 'Complete.' It Never Mentioned the Boy Who Died.
A boy died in a Chinese gene-therapy trial in August 2025. Months later the registry marked the study 'complete' and never mentioned him. He is one of three deaths now pulling Congress toward the trial data U.S. drugmakers ship home from China, while American inspectors almost never see the sites th
InvestigationsTwo Words Open Fauci's Pandemic Diary: 'GAME ON!!!'
Anthony Fauci's private diary greets the pandemic with 'GAME ON!!!' and, in the same January 2020 entry, records that the first infection traced to early December and that the Wuhan market was 'the amplifier,' not the source.
Investigations'No Falsification': JAMA Keeps a Purdue-Funded Opioid Paper Its Own Retraction Rule Says to Pull
Court records from a 2007 federal case show Purdue had flagged 8 possible-withdrawal cases a year before its 2000 study called withdrawal rare. The journal says that isn't falsification, so the paper stays in print.
InvestigationsRFK Jr. Promised Radical Transparency. His HHS Gutted the Staff Who Release FDA Inspection Reports and CDC Outbreak Data.
The FDA, CDC, and NIH fielded more than 15,000 records requests in 2024. In April 2025 HHS fired the staff who answer them, rehired some FDA workers a month later under legal pressure, and by August 2026 the federal records backlog had only grown.
InvestigationsVitamin K Shot Refusals Nearly Doubled Since 2017. A Cancer Scare Refuted Twenty Years Ago Still Shadows It.
Refusal of the newborn vitamin K shot has nearly doubled since 2017. The injection all but erases a bleed that kills roughly one in five infants it reaches, and the cancer scare still shadowing it was refuted twenty years ago. The institutions losing these parents will not even count the damage.
InvestigationsTwo Scientists Nominated Fauci for Cash Prizes. Then His Agency Funded Them by the Hundreds of Millions.
The emails Rand Paul released July 24 show Fauci's taxpayer-funded staff drafting his award nominations, and two scientists who submitted them going on to draw large NIAID grants.
InvestigationsBuilt to Find Nothing: Merck Tested Gardasil's Safety Against Its Own Aluminum Adjuvant
In ten of eleven pivotal trials, Merck's Gardasil 'placebo' was 225 micrograms of the same aluminum adjuvant that is in the vaccine, and serious harms counted only inside a 14-day window.
InvestigationsA Gene-Editing Trial Killed a Six-Year-Old. The Only Official Penalty Was a $3,500 Fine.
Xinhua Hospital paid about 24,000 yuan in September 2025. The death it was fined over stayed out of the medical literature for another ten months, and out of the Nature paper entirely.
InvestigationsA Gene-Editing Trial Killed a 6-Year-Old. Nature Published the Science and Left Her Out of the Record.
Her parents paid $860,000 to base-edit their daughter's brain. She died of an immune reaction within a week, the trial's fatal outcome was never disclosed, and the Nature paper built on the same work never names her.
InvestigationsNEJM Retracted the Study That Approved Amgen's Vasculitis Drug. It Had Never Done That in 200 Years.
The FDA says the drug's superiority result came from re-scoring nine patients after the trial was unblinded. It is still on U.S. shelves while Amgen fights the withdrawal.